PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 65 filers reported holding PARDES BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 5,227,307 | $37,741,000 | 52.85% |
| Foresite Capital Management V, LLC | 9,400,515 | $67,872,000 | 27.72% |
| Lynx1 Capital Management LP | 1,642,834 | $11,861,000 | 11.01% |
| Frazier Life Sciences Management, L.P. | 2,081,007 | $15,025,000 | 1.28% |
| RA Capital Management | 6,175,038 | $44,584,000 | 0.97% |
| Arena Capital Advisors, LLC- CA | 851,281 | $6,146,000 | 0.93% |
| DAFNA Capital Management LLC | 421,157 | $3,041,000 | 0.79% |
| Sio Capital Management, LLC | 315,564 | $2,278,000 | 0.75% |
| TCG Crossover Management, LLC | 229,100 | $1,654,000 | 0.66% |
| Altium Capital Management LP | 253,000 | $1,827,000 | 0.61% |